Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06564636 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System

Study acronym: CATALYSTEM
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Dec 2026 to Dec 2027v8 Show 7 more changesShow less
    • Primary endpoint revised
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Enrollment target: estimated 198 to confirmed 119
    • Study completion date: Feb 2030 to Mar 2036
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints revised (4)
    • Study description revised
  2. Minor Study sites: 12 to 10v7
  3. Minor 3 versions Re-verified since Jun 4, 2025, no change to tracked fieldsv4-v6
  4. Minor Study sites: 10 to 12
    • Eligibility criteria shortened, about 9 words
    • Secondary endpoints: 10 to 4
    v3
  5. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Aug 2024 to Sep 26, 2024
    • Site contacts updated at 10 of 10 sites
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
Trial Details
NCT Number NCT06564636
Lead Sponsor Smith & Nephew, Inc.
Conditions
(from sponsor)
Total Hip Arthroplasty (THA), Osteoarthritis, Degenerative Joint Disease, Inflammatory Arthritis, Avascular Necrosis, Post-traumatic Arthritis, Congenital Hip Dysplasia
Related terms Arthritis, Hip Dislocation, Congenital, Joint Diseases, Osteoarthritis, Osteonecrosis
Enrollment 119 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov